Zhang, G.; Pannucci, A.; Ivanov, A.A.; Switchenko, J.; Sun, S.-Y.; Sica, G.L.; Liu, Z.; Huang, Y.; Schmitz, J.C.; Owonikoko, T.K.
Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer. Cancers 2025, 17, 446.
https://doi.org/10.3390/cancers17030446
AMA Style
Zhang G, Pannucci A, Ivanov AA, Switchenko J, Sun S-Y, Sica GL, Liu Z, Huang Y, Schmitz JC, Owonikoko TK.
Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer. Cancers. 2025; 17(3):446.
https://doi.org/10.3390/cancers17030446
Chicago/Turabian Style
Zhang, Guojing, Abbe Pannucci, Andrey A. Ivanov, Jeffrey Switchenko, Shi-Yong Sun, Gabriel L. Sica, Zhentao Liu, Yufei Huang, John C. Schmitz, and Taofeek K. Owonikoko.
2025. "Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer" Cancers 17, no. 3: 446.
https://doi.org/10.3390/cancers17030446
APA Style
Zhang, G., Pannucci, A., Ivanov, A. A., Switchenko, J., Sun, S.-Y., Sica, G. L., Liu, Z., Huang, Y., Schmitz, J. C., & Owonikoko, T. K.
(2025). Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer. Cancers, 17(3), 446.
https://doi.org/10.3390/cancers17030446